The association between insulin resistance (IR) and depression is a subject of growing research interest, especially as previous population-based studies have presented conflicting findings. The present study extends our understanding about the putative impact of the severity of depressive symptoms on this association and it provides further epidemiological evidence in support of earlier findings, suggesting that the association between IR and depression is present already in young adult males. To determine the impact of the severity of depressive symptoms on the putative association between IR and depression in young adult males, we were given access to the Northern Finland 1966 Birth Cohort database. During the 31-year follow-up survey of this genetically homogeneous birth cohort, IR was assessed by 'Qualitative Insulin Sensitivity Check Index' (QUICKI), and severity of depressive symptoms by 'Hopkins' Symptom Checklist-25' (HSCL-25). This study involved 2609 male cohort members with complete variable information. In men, the means of the QUICKI-values decreased (i.e., IR increased) in line with the increased severity of depressive symptoms as assessed by HSCL-25 subgroups (analysis of covariance P-value for trend, P = 0.003). In multivariate generalized logistic regression analyses, after adjusting for confounders, IR was positively associated with current severe depressive symptoms, the odds ratio (OR) being over threefold (adjusted OR 3.15, 95% confidence interval 1.48-6.68) and the value of OR increased in parallel with a tighter definition of IR (P-value for trend = 0.007). The results indicate that in young males, a positive association exists specifically with severe depressive symptoms. Molecular Psychiatry (2006) 11, 929-933.
Introduction
The link between type II diabetes and depression has been of considerable interest to researchers recently. 1 Yet, the association between depression and insulin resistance (IR), representing an important fundamental metabolic defect in type II diabetes, is a poorly studied area. 2 However, despite numerous methodological limitations, earlier studies, which were mainly based on clinical data sets, have pointed to a positive association between IR and depression. 2, 3 A corresponding positive association between IR and depressive symptoms was also reported in a populationbased study of subjects aged 61-63 years. 4 There are, however, studies that indicate that IR is not associated with depression and that IR may even protect against depression. 5, 6 The few earlier population-based investigations [4] [5] [6] have presented conflicting findings regarding an association between IR and depression. This discrepancy could at least partly be explained by the fact that the impact of the severity of depressive symptoms on this association has, thus far, been an unheeded issue. We used, therefore, the large Northern Finland 1966 Birth Cohort database to investigate any putative association between IR and depressive symptoms, and secondly, whether such association depended on the severity of the depressive symptoms.
Materials and methods

Study sample
We used data from the large and genetically homogeneous Northern Finland 1966 Birth Cohort. In the two northernmost Finnish provinces, that is, Oulu and Lapland, 96% of all the women (n = 12 068), with an expected date of delivery falling between 1 January and 31 December 1966, were evaluated; they gave birth to 12 058 live infants, all of European Caucasian origin. A variety of biological, socio-economic and health-related conditions as well as living habits and family characteristics of the cohort members were collected prospectively through prenatal stages up to the age of 31. A detailed description of the data set has been presented in several previous studies. 7 In 1997, 8463 (4389 men and 4074 women) cohort members, who were living in Northern Finland or in the capital area, were sent postal questionnaires and invited to undergo a clinical examination; 6033 (71.3 %), of which 48% were male subjects, attended. As female hormones may play an important role as confounding factors in the association between IR and depression in women, 3, 8, 9 and owing to the methodological limitation that our data did not include information on the female hormonal status, we based our analyses exclusively only on the 2609 men, who had consented in writing to the use of their collected data for scientific purposes. Characteristics of the study population are presented in Table 1 . The study was approved by the Ethics Committee of the Faculty of Medicine, University of Oulu (Finland).
Case definitions
The Qualitative Insulin Sensitivity Check Index (QUICKI) was determined according to the equation: QUICKI = 1/[log(I0) þ log (G0)], in which I0 is fasting insulin and G0 is fasting glucose, 10 measured during clinical examinations. Insulin resistance, using the WHO cutoff point, was defined as the lowest quartile of the QUICKI of our study population. 11 In addition, the lowest quintile and decile of the QUICKI were also used to explore whether more strictly defined IR is associated more strongly with depressive symptoms.
Information on depressive symptoms was obtained through Hopkins' Symptom Checklist-25 (HSCL-25), [12] [13] [14] [15] [16] which was included in the above mentioned postal questionnaires. HSCL-25 is a 25-item shortened version of an originally 90-item questionnaire designed by Degoratis et al. 12 A depression subscale consists of 13 items. 13 Cohort members recorded their estimates of severity of their depressive symptoms on a scale ranging from 1 ('not at all') to 4 ('extremely'). Responses were summed and divided by the number of answered items to generate a depression mean score ranging from 1.0-4.0. This mean score was utilized to assign the cohort members to subgroups according to the severity of their depressive symptoms. In this study, mean scores of X1.55, X1.75 and X2.01 in the HSCL-25 depression subscale were used to assess the severity of current depressive symptoms. [13] [14] [15] [16] The data concerning IR and depressive symptoms was available from 2616 men, of which seven subjects with earlier diagnosed diabetes were excluded, leaving 2609 male cohort members for our analyses. Information on diabetes was obtained through postal questionnaires during the 31-year follow-up survey by posing the following question: 'Have you ever had diabetes verified or treated by a doctor (yes/no)?'
Statistical methods
Data are presented as mean7standard deviation (s.d.) and proportions. Analysis of variance was used to compare mean differences and the trend in the means of QUICKI across the severity of current depressive symptoms. Potential confounders, that is, socio-economic status, body mass index, smoking, alcohol intake, physical inactivity, serum level of high-sensitivity C-reactive protein, fasting serum level of cholesterol and hospital treated physical disease were controlled in the analysis of covariance (ANCOVA). Dunnett multiple comparison tests were used for post hoc comparisons of QUICKI regarding severity of current depressive symptoms, whereas those without depressive symptoms (i.e., HSCL-25 mean score < 1.55) were treated as a reference group.
Multivariate generalized logistic regression analyses were used to explore the association between IR and severity of current depressive symptoms Insulin resistance and depressive symptoms M Timonen et al (adjusting for the above-mentioned potential confounding variables), and the results were reported using adjusted odds ratios (OR) and their 95% confidence intervals (95% CI). The statistical analyses were performed using the SAS (version 8.02) for Windows.
Results
In cohort males, means of the QUICKI-values decreased (i.e., IR increased) in line with the increased severity of depressive symptoms as assessed by HSCL-25 depression subscale subgroups (ANCOVA P-value for trend, P = 0.003). The means of the QUICKI-values were 0.3492, 0.3490 and 0.3425 in HSCL-25 depression subscale subgroups of 1.55-1.74, 1.75-2.00 and 2.01-4.00, respectively, whereas the mean was 0.3492 in the reference group (Table 2) . In pairwise comparisons, the mean of the QUICKIvalues regarding the HSCL-25 depression subgroup of 2.01-4.00 differed statistically significantly from that of the reference group (ANCOVA P-value = 0.002).
Results regarding the association between IR and depressive symptoms, based on multivariate generalized logistic regression analyses, are shown in Table  2 . In male subjects, after adjusting for confounders, IR was positively associated with current severe depressive symptoms (i.e., HSCL-25 depression subscale mean scores X2.01), the ORs increasing from 2.18-to 3.15-fold in parallel with a tighter definition of IR (P-value for trend = 0.007).
Discussion
The major finding of this Northern Finland 1966 Birth Cohort study was that concomitant IR was positively associated with current severe depressive symptoms in young adult males. This finding is on a par with earlier ones based on clinical data sets showing that patients with depression exhibit IR. 2, 3 It also agrees with earlier population-based study of subjects aged 61-63 years, which showed a positive correlation between IR and severity of depressive symptoms. 4 Our finding is also in line with those earlier ones that have shown an association between depression and type II diabetes. 1, 17 We consider, however, our finding important, as in the present study, the association between IR and depressive symptoms was confirmed in young adult males, in which earlier diagnosed diabetes was excluded. Further investigations are, however, called for to confirm our results, as according to a recent prospective cohort study, no association was found between IR and depressive symptoms in middle-aged men. 6 The etiology of IR in depression has, until now, remained unknown, but it may be multifactorial. 3 Hypothalamus-pituitary-adrenal hyperactivity, genetic mechanisms and disturbances in the serotonin system have been established as potential biological mechanisms behind the association. 3 Furthermore, subclinical chronic low-grade inflammation is also associated with depression 3 and IR, 18 and thus could serve as a potential pathophysiological mechanism underlying the association. a QUICKI25, QUICKI20 and QUICKI10 are the lowest quartile, quintile and decile, respectively, of the QUICKI of the study population. Percentages (%) are the proportions of cohort members with IR defined by corresponding QUICKI according to different HSCL-25 depression subscale scores. b QUICKI was determined according to the equation: QUICKI = 1/[log(I0) þ log (G0)], in which I0 is fasting insulin and G0 is fasting glucose, 10 measured during clinical examination. c Adjusted for; socio-economic status; body mass index; smoking; alcohol intake; physical inactivity; serum level of highsensitivity C-reactive protein; fasting serum level of cholesterol; and hospital treated physical disease. d ANCOVA P-value for trend, P = 0.003. e P-value for trend = 0.007.
Regarding causality, there is evidence that IR is a state-dependent metabolic abnormality in depressive disorders, suggesting that depression would cause IR. 3 Conversely, IR may play a role in the pathogenesis of depression. 3 In our study, causality could not be evaluated and remains to be investigated. We speculate that causality between these disorders could also be bi-directional. If so, one disorder could be prevented by treating or preventing the other, which would be of great public health importance. Consequently, the impact of different types of antidepressants on depression with and without IR should be investigated.
We were, however, able to provide at least some evidence about the gradient effect regarding the association between IR and depressive symptoms in young adult males: on the one hand, IR increased (i.e., the mean score of the QUICKI decreased) in line with the increased severity of depressive symptoms, and on the other hand, with the most severe cases of depressive symptoms (i.e., HSCL-25 depression subscale means scores X2.01), the value of OR increased in parallel with a tighter definition of IR. These findings need, however, to be replicated in future studies by other databases with more reliable instruments for detecting depression.
Limitations of our study were that the data regarding QUICKI and HSCL-25, even though our study material was based on a prospectively followed up birth cohort, was collected cross-sectionally. Further, the HSCL-25 does not provide a specific depression diagnosis like structured clinical interviews. In addition, our data did not include information on the female hormonal status, which together with the use of oral contraception might play an important role as confounding factor in the association between IR and depression in women. 3, 8, 9, 19 Consequently, we could not investigate the possible influence of gender on the association under debate. Recently, Rasgon et al. 19 found that in a clinical sample of women with polycystic ovary syndrome, which is characterized by hyperandrogenism and IR, 50% of the patients were considered depressed. Further, while confirming an independent association between depression and type II diabetes, a large population-based investigation 17 suggested also that the relationship between depression and IR-related conditions (like type II diabetes, cardiovascular disease and obesity) differed between men and women. Therefore, further investigations regarding the impact of gender on the association between IR and depression are needed. Also, owing to the fact that depressive symptoms were measured only during the 31-year follow-up survey of the Northern Finland 1966 Birth Cohort, we could not study the possible impact of age on the association under investigation. This is, thus, another issue that deserves to be further investigated.
The strengths of our study were that it was based on a large, unbiased and genetically homogeneous prospectively followed up birth cohort. Secondly, QUICKI has been shown to be a reliable instrument in screening insulin sensitivity. 10 Thirdly, HSCL-25 has proven to be an acceptable screening scale for obtaining information on symptoms of depression in the normal population. 15 In conclusion, we found a significant association between IR and concomitant severe depressive symptoms in young men without earlier diagnosed diabetes. In addition, in men with the highest mean scores of the HSCL-25 depression subscale, the strength of the association increased in line with tightening the definition of IR. On the other hand, IR increased in parallel with increasing severity of depressive symptoms. Even though we could provide some additional evidence regarding a positive association between IR and depressive symptoms in young adult males, the causality between the two, however, remains to be investigated in prospective follow-up studies. Owing to the fact that we could not reliably conduct our analyses with women, further investigations on this issue are called for among both genders.
